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Abstract
Photodynamic therapy (PDT) is a cancer treatment involving the administration of a photosensitising drug which selectively accumulates in tumor tissue, followed 
by irradiation with appropriate wavelength light. It triggers photochemical reactions inducing reactive oxygen species (ROS) production with the consequent cellular 
damage, which ultimately leads to cell death. Porphyrins are the only photosensitizers (PSs) endogenously synthesized by means of administration of the biological 
precursor, 5- aminolevulinic acid (ALA). Several antioxidants and ROS scavenger agents: reduced glutathione (GSH), mannitol (Man), l-tryptophan (Trp), ascorbate 
(Asc) and trolox (Trx), were assayed to determine their ability to modulate ALA-based PDT (ALA-PDT); it was performed on A549 human lung adenocarcinoma 
cells, by incubating with 1mM ALA for 3 hr and followed by irradiation with or without 1 hr pre-incubation with the modulators. They were previously tested for 
possible cytotoxicity/ photoactivity in concentrations ranging from 0.01 to 20 mM. The ratio between cell survival after ALA-PDT in the presence and in the absence 
of the scavenger agent (protection grade: PG) was determined, and the concentration showing no cytotoxicity/ photoactivity and providing the highest PG was used 
in the subsequent experiments. ALA-PDT alone induced a high percentage of apoptotic cell death (98.4 ± 3.5%) as revealed by acridine orange/ethidium bromide 
staining and AnnexinV-FITC/propidium iodide labelling. Pre-incubation with the modulators at their highest PG concentration significantly reduced apoptotic cells 
to 48.3 ± 2.7% (Asc), 58.8 ± 4.2 (Trx), 78.5 ± 3.1% (GSH), 64.3 ± 1.6% (Man), 74.6 ± 2.3% (Trp). ROS involvement in early cell death induction after ALA-PDT 
was tested by flow cytometry using the fluorescent probes dihydro-dichlorofluorescein diacetate (H2-DCFDA) and methoxyvinylpyrene (MVP) for detection of 
peroxides and singlet oxygen, respectively. ROS production increased after ALA-PDT (H2-DCFDA positive cells, control: 1.1 ± 0.1 %; 10 min-PDT: 69.3 ± 5.6%; 
MVP positive cells, control: 0.65 ± 0.35%; 10 min-PDT: 83.5 ± 1.9%). Asc prevented peroxide formation (H2-DCFDA positive cells: 50.7 ± 2.8%) and mostly 
prevented singlet oxygen increase (MVP positive cells: 25.4 ± 5.2%) whereas Trx limited peroxides formation (H2-DCFDA positive cells: 20.8 ± 0.5%), but did not 
significantly affected singlet oxygen production (MVP positive cells: 73.6 ± 3.4%). Selective scavenger mediated protection against PDT-induced cell death, and direct 
detection of specific pro-oxidative agents, entail the strong involvement of ROS in ALA-PDT-mediated tumor eradication, suggesting that undesired photodamage 
to normal tissue might be attenuated by administration of antioxidant agents.
Introduction 
PDT is a minimally invasive therapeutic procedure applied for 
obstructive, superficial and endoscopically accessible tumors as well 
as premalignant and non oncological disorders [1-3]. It involves the 
administration of a photosensitizing drug (PS) – often a porphyrin 
- which is selectively accumulated in malignant tissue. Subsequent 
irradiation with appropriate wavelength light triggers the excitation of 
the PS and the generation of ROS, mainly singlet oxygen, selectively 
destroying the target cell through the oxidation of cellular constituents, 
which damages plasma membranes and subcellular organelles [4,5]. 
The advantages of PDT over conventional therapies are the relatively 
high selectivity and low systemic toxicity, and so, PDT is being 
currently used for the treatment of many cancers such as bladder, 
brain, lung, gastrointestinal and gynaecological neoplasms, and also in 
dermatology and non-oncological disorders [6-14]. 
There are many different PSs, both synthetic and natural, most 
of them heterocyclic compounds with double bonds [4,5,15]. Among 
them, porphyrins are the only PS endogenously generated by the 
administration of its biological precursor 5-ainolevulinic acid (ALA), 
inducing the accumulation of Protoporphyrin IX (PpIX), which is a 
highly photosensitive compound [16], known to be responsible for the 
skin photodamage and cutaneous lesions in patients with Erythropoietic 
Protoporphyria, a hereditary disorder caused by a deficiency in the 
enzyme Ferrochelatase involved in heme biosynthesis [17]. ALA and 
its ester derivatives have been successfully used to visualize and destroy 
malignant cells in experimental and clinical trials [18-23]. 
Conventional cancer therapy produces, in many cases, ROS which 
attack healthy cells and tissues leading as a consequence, to further 
damage and unintentional side effects. Antioxidants, owing to their 
free radical scavenger capacity, are able to decrease these adverse effects 
[24]; however, it must be taking into account that any antioxidant found 
to reduce toxicity of tumor therapy on healthy tissue has in addition the 
potential to decrease effectiveness of cancer therapy on malignant cells. 
Tumor eradication by PDT involves several cell death types 
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including necrosis, apoptosis and also autophagy [25-28]. These death 
pathways are not mutually exclusive; moreover, they can coexist and 
occur simultaneously under certain physiological or pathological 
conditions [29]. PDT causes cell death by irreversible photodamage 
to vital subcellular targets. The PS intracellular localization determines 
the primary site of photodamage, playing a key role on the cell death 
pathway. Since PSs rarely locate at nuclei, damage to DNA is limited. 
Generally, photoactive compounds localizing to mitochondria or 
endoplasmic reticulum promote apoptosis within a certain threshold 
of oxidative stress [28]. It has also been reported that certain PSs, such 
as, mono-L-aspartyl chlorine e6 (NPe6), cause an almost immediate 
disruption of the lysosomes after laser irradiation [30,31].
Apoptosis is a neatly regulated process, and the most extensive cell 
death pathway triggered by PDT. It is controlled by both intracellular 
and extracellular signals, ending in a characteristic sequence of 
morphological and biochemical changes for the systematic dismantling 
of the cell and preparation of the residual cell components, known as 
apoptotic bodies [26]. The cytotoxicity of PDT protocols, however, 
cannot be fully explained by the apoptotic response. With high PDT 
doses or PS localizing at the plasma membrane, necrosis is frequently 
observed [32]. This mode of cell death is represented by morphological 
signs such as vacuolization of the cytoplasm, swelling and breakdown 
of the plasma membrane resulting in an inflammatory reaction due 
to release of cellular contents and pro-inflammatory molecules. In 
addition, autophagy, characterized by the sequestration of cytoplasmic 
material in vacuoles for degradation by lysosomal enzymes, although 
a way of self-destruction, is not invariably a process of cell death; on 
the contrary, autophagy often protects against cell death removing 
damaged organelles or catabolising cellular macromolecules [28,33].
In the present study we characterize the cellular response to ALA-
PDT in the human A549 lung adenocarcinoma cell line, and report 
on the ability of several antioxidant agents to prevent cell death after 
treatment and their implications in modulating PDT efficacy and ROS 
participation.
Materials and methods
Chemicals
ALA, H2DCF-DA, MVP, dihydroethidine (HE), Rhodamine123 
(Rh 123), Asc, Man, GSH, Succinil Acetone (SA) and Deferroxamine 
(Dfx) were obtained from Sigma Chem. Co. (USA). MitoTracker and 
LysoTracker Green were purchased from Mollecular Probes Inc, and 
Annexin V-FITC from Invitrogen (Argentina). All other chemicals 
used were of analytical grade.
Cell line and cell culture
The human A549 lung adenocarcinoma cell line (non-small 
cell lung cancer, NSCLC) was grown at 37°C in 5% CO2 humidified 
atmosphere in Minimum Essential Medium (MEM) supplemented 
with 5% foetal calf serum (FCS), 80 µg/ml gentamicin and 2 mM 
l-glutamine. To perform the experiments cells at densities from 5 x 104 
to 1 x 105 cells /ml were seeded in 24 or 6-well plates, according to the 
assay.
ALA-PDT treatment
As a standard procedure, cells were allowed to grow until 
subconfluence, then, culture medium was replaced by serum free 
medium to avoid porphyrin externalisation [34], and incubated 3 hr 
with 1 mM ALA final concentration. Afterwards, cells were illuminated 
with two fluorescent lamps (Osram L 18W/765) emitting wavelengths 
over the range 400 - 700 nm with the highest radiant power at 600 nm 
(0.4 J/cm2) and located at 21 cm from the plates. The percentage of viable 
cells after PDT was determined by the MTT (3(4,5-dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide) assay [35].
Modulators of porphyrin biosynthesis and antioxidants
SA and Dfx were prepared at 20 mM concentration, dissolved in 
distillate water and PBS, respectively. To assess a putative protecting 
effect of several antioxidant and scavenger agents (Trp, GSH, Man, Asc 
and Trx), they were dissolved in PBS and added to the cell culture 1 
hr before ALA administration; then, incubation and irradiation were 
performed as described previously. 
Subcellular localization of ALA-induced PpIX
Cells were seeded on coverslips at the bottom of 6-well plates and 
grown to subconfluence. After 18 hr incubation with 1 mM ALA, cells 
were loaded with 150 nM MitoTracker Green or LysoTracker Green 
for 30 min at 37°C. Coverslips were mounted on slides and examined 
with confocal microscope (Nikon C1, objective: 60x Plan Apo Oil NA 
1.40).
Mitochondrial and lysosomal damage after PDT
Cells were grown on coverslips as mentioned above, and incubated 
with 1 mM ALA during 2.5 hr; then, 150 nM MitoTracker Green or 
LysoTracker Green were added and the incubation continued for 30 
min. Plates were irradiated for 10 min and examined 1 hr later under 
fluorescence microscopy (Olympus BX51) for organelle morphology.
Toluidine blue and Hoechst staining
Cells grown on coverslips were submitted to ALA-PDT as 
mentioned above and fixed 1 hr after treatment in 4% formaldehyde for 
20 min at 4°C (Toluidine blue staining) or 7 min in methanol at -20°C 
and permeabilized with 0.1% Tritón X-100 in PBS (Hoechst staining). 
Coverslips were washed 4 times for 5 min with cold PBS. After washing 
once with PBS, 0.5% Toluidine blue or 40 µl of 1 µg/ml Hoechst 33258 
was added, and cells were observed under fluorescence microscopy 
(Olympus BX51) for nuclear morphology.
Cellular morphology assessment with acridine orange and 
ethidium bromide double staining
Acridine orange penetrates into living and dead cells emitting 
green fluorescence as a result of intercalation into double stranded 
DNA, and red-orange fluorescence after binding with single stranded 
DNA due to its accumulation in lysosomes. Ethidium bromide emits 
red fluorescence after intercalation into DNA of cells with altered 
membranes at late apoptosis stages or necrosis. Thus, the combination 
of these two fluorochromes allows distinguishing four cell states: living 
cells (green nucleus), early apoptotic cells (chromatin condensation, 
green nuclei), late apoptotic (orange and condensed or fragmented 
nuclei) and necrotic cells (uniform orange dyed nuclei). Briefly, 1 hr after 
ALA-PDT cells were trypsinized, washed with PBS and resuspended at 
1 x 106 cells /ml. Then, 2 µl of the fluorochromes mixture (50 µg/ml 
each) was added and cells examined under fluorescence microscopy 
(Olympus BX51). At least 200 cells were counted for each treatment.
Phosphatidylserine exposure detection with annexin V-FITC 
labelling and propidium iodide staining
1 hr after ALA-PDT cells were trypsinized, washed with PBS and 
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resuspended at 2 x 106 cells/ml in binding buffer containing 10 mM 
HEPES/NaOH, pH 7.4; 140 mM NaCl, 2.5 mM CaCl2 . Aliquots of 100 
µl were incubated for 15 min at room temperature with 5 µl Annexin 
V-FITC. Later, propidium iodide was added to a final concentration of 
5 µg/ml and volume was completed to 500 µl. Samples were analyzed 
with a Partec PAS III flow cytometer. 
Reactive oxygen species production
For ROS detection, cells from 24 hr culture were trypsinized 1 h 
after ALA-PDT treatment and incubated 30 min in the dark at 37°C 
with one of the following ROS fluorescent detection probes: 10 µM H2-
DCFDA (λ emission: 530 nm), 10 µM MVP (λ emission: 465 nm), 2 
µM HE (λ emission: 461 nm) or 10 µM Rh 123 (λ emission: 534 nm). 
Samples were analyzed with a Partec PAS III flow cytometer.
Statistical analysis
The values are expressed as means ± standard error of the mean, and 
they are the average of three independent experiments run in triplicate. 
Data were analyzed with GraphPad Prism (GraphPad Software Inc., 
San Diego, CA, USA).
Results
Response to ALA-PDT is light dose – dependent
PpIX accumulated after incubation with increasing concentrations 
of ALA from 0.1 to 5 mM for 3 hr raised until a plateau at 1 mM, 
reaching 11.67 ± 0.18 ng/105 cells. At different incubation times, from 
1 to 8 hr, PpIX levels kept linearly rising up to 29.89 ± 1.45 ng/105 
cells. The amount of porphyrins released to the cell medium did not 
contribute significantly to the total porphyrin production. ALA did not 
produce considerable dark toxicity at any concentration or incubation 
time as verified by the MTT assay. In the absence of porphyrins, 
the most prolonged irradiation time used (15 min) did not alter the 
survival of the cells (data not shown). Therefore, the conditions for 
the subsequent PDT treatments were established at 1 mM ALA final 
concentration and 3 h incubation. Once ALA-PDT was performed, 
cell viability was determined 1 h after treatment and it was found to 
decrease as irradiation time increased, reaching almost 90% cell death 
at 15 min and 50% at 7 min irradiation, determining this last value the 
LD50 for the cell line (Figure 1).
ALA- induced PpIX accumulates in mitochondria
PpIX distribution in the cells can be visualized by its own red 
fluorescence whereas mitochondria and lysosomes were visualized 
by means of the specific probes Mito Tracker and Lyso Tracker 
Green. Confocal images (Figure 2) showed that following incubation 
with ALA, the red fluorescence of PpIX co-localized with the green 
fluorescence of organelle probes only when visualizing mitochondria 
but not lysosomes.
Cell and organelle morphology indicate apoptotic cell death 
after ALA-PDT
We next examined morphological changes in ALA-PDT treated 
cells, as revealed by Toluidine blue and Hoechst staining by conventional 
and fluorescence microscopy respectively. Representative images are 
shown in Figure 3. Immediately after illumination, cells detached from 
the substrate. Severe damage to the membrane and nucleus after 7 min 
ALA-PDT can be seen, whith picnotic nucleus and a marked reduction 
in the cell size, together with a prominent membrane blebbing. As the 
irradiation time increased, it can be observed progressive detachment, 
rounding, membrane blebbing and nuclei condensation (Figure 3 
panels B and C) revealing morphological features of cells undergoing 
apoptosis. The highest PDT dose tested (15 min) produced a low 
percentage of membrane swelling consistent with necrotic features 
(Figure 3A). 
Also double staining with acridine orange/ethidium bromide 
revealed high percentages of cells with chromatin condensation and 
membrane blebbing consistent with apoptosis, rising from 10.2 ± 
1.1% in untreated cells to 98.3 ± 3.5% for 15 min ALA-PDT (Figure 
3 panel D, Figure 4A). Membrane phosphatydil-serine externalisation 
is another apoptosis induction sign. Labelling with Annexin V- FITC/ 
propidium iodide staining allows distinguishing necrotic, and early and 
late apoptotic cells from viable ones. Consistent with acridine orange/
ethidium bromide results, the yield of apoptotic cells assessed by flow 
cytometry increased with irradiation time (Figure 3 panel E, Figure 4B) 
from 2.3 ± 0.1% in untreated cells to 64.2 ± 5.5% for 15 min ALA-PDT. 
At all time PDT doses, the percentage of necrotic cells remained low.
Forward (FSC) and side scatter (SSC) of light reflected by cells 
in a flow cytometer represent granularity and cell size, respectively. 
Apoptotic cells typically show a reduced cell size and increased 
granularity due to cell constriction and apoptotic bodies formation. 
Therefore, FSC-SSC plots complement Annexin/propidium iodide 
Figure 1. Effect of increasing irradiation time on cell survival. Cells were incubated for 3 
hr in serum-free media with (●) or without (○)  1 mM ALA,  followed by  irradiation with 
fluorescent lamp during different  times;  1h later MTT assay was performed. Bars: SE 
based on three independent experiments with three parallels in each.
Figure  2.  ALA- induced PpIX localization.  
Fluorescent confocal images of cells incubated with ALA (A and D), ALA plus MitoTracker 
Green (B) or ALA plus LysoTracker Green (E) and the corresponding merging (C and 
F). Briefly, cells grown on coverslips were incubated for 18 hr with 1mM ALA and then 
loaded with 150  nM MitoTracker or LysoTracker Green,  and visualized under confocal 
microscopy (Nikon C1, objective: 60x Plan Apo Oil NA 1.40; scale bar: 20 µm).
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plots with simultaneous morphological data. As can be seen in Figure 
3 panel F, FSC-SSC plots show the progressive cell size reduction and 
increasing granularity consistent with the apoptotic process.
In order to assess organelle damage after ALA-PDT, cells were 
incubated and then irradiated in the presence of specific probes 
for mitochondria and lysosomes. In untreated cells, Mito and Lyso 
Tracker are taken up by polarized mitochondria or intact lysosomes 
respectively. After depolarization of mitochondrial membrane or 
lysosome disruption, the probes are released to the cytoplasm, showing 
uniform pattern of the fluorescence instead of that corresponding to 
the normal organelle localization and distribution. Therefore, these 
features are signs of damage to the organelles. In our case, 10 min 
irradiation time produced not only cell detachment but also the loss 
of the punctuate pattern for lysosomes and mitochondria observed in 
control cells (Figure 5). Although the fluorescence distribution after 
the irradiation was diffuse but not absolutely uniform, it is consistent 
with a marked externalization of the probes, indicating disruption of 
organelle integrity.
Figure 3.  Changes in cell morphology at different time-dose ALA-PDT.  
Cells were incubated with 1 mM ALA for 3 hr and then irradiated 2, 5, 7, 10 and 15 min. After 1 hr, cells still attached to coverslips were fixed and stained with Toluidine blue (panel A) or 
Hoechst (panels B and C) and visualized under conventional or fluorescence microscopy. In parallel experiments, cells were trypsinized and stained with acridine orange / ethidium bromide 
(panel D) and visualized under  fluorescence microscopy, or labelled with Annexin V-FITC /propidium iodide (panel E) and analyzed by flow cytometry. Cell size and granularity were 
assessed by light scattering by flow cytometry (panel F). Scale bars for panels A, B and C: 100 µm and for panel D: 150 µm.
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Modulating agents affect differentially ALA-PDT-treated 
cells viability
Porphyrin synthesis induced by exogenous administration of ALA 
and therefore, cell death after irradiation, can be regulated by several 
agents. As a first attempt to modify the outcome of PDT, we tested 
compounds whose effects on heme metabolism are well known. In 
this way, we verify the ability of our PDT system to be modulated by 
both increasing and decreasing porphyrin synthesis and/or cell death. 
As expected, SA, an inhibitor of 5-aminolevulinic acid dehydratase 
(the second enzyme of the heme biosynthetic pathway) significantly 
reduced ALA- induced porphyrin synthesis almost to control levels 
and also decreased cell death after illumination. On the other hand, 
the iron quelating agent Dfx enhanced cell death after ALA-PDT by 
lowering the available iron for the last step on heme biosynthesis and 
consequently inducing the accumulation of heme precursors (Figure 6).
Considering ROS are one of the earlier and major effectors of 
cell death induced by PDT, we tested several antioxidants and free 
radical scavenger on agents on their ability to modulate the treatment 
outcome; these compounds either neutralize or hijack ROS.
Various agents of distinct chemical nature with known antioxidant 
or ROS scavenger effect were employed: Man, Trp, GSH, Asc and 
Trx. To verify that none of them presented cytotoxicity/photoactivity, 
cell viability assays were performed incubating cells with different 
concentrations of the scavengers, ranging from 0.1 to 20 mM, and 
submitted to 10 min irradiation. We did not find any photosensitizing 
action by of the scavengers themselves, and none of the agents showed a 
any stimulation of cell death. Those concentrations presenting toxicity 
were discarded for the following experiments. The agents were tested 
for any alteration of porphyrin synthesis as well, but none of them 
significantly increased or decreased porphyrin levels (data not shown). 
Once this was checked, the ability of the compounds to modulate the 
viability of ALA-PDT treated cells was assessed in the whole selected 
concentration range. 
To compare the effect of the compounds tested, we defined 
protection grade (PG) as the ratio between the cell survival after ALA-
PDT in the presence of the scavenger agent relative to survival in its 
absence, and those concentrations bearing the highest PG were selected 
to perform the following experiments (Figure 7).  Maximum PGs were 
found at different concentrations, depending on the compound (1 mM 
GSH, PG: 2.1 ± 0.3; 10 mM Man, PG: 1.1 ± 0.1; 1 mM Trp, PG: 1.7 ± 
0.1; 1 mM Asc, PG: 2.6 ± 0.1; 1 mM Trx, PG: 3.5 ± 0.1), eeffects which 
can be attributed to the chemical nature and the particular quelating 
action of each agent.
Scavenger agents protect against ALA-PDT-induced 
apoptosis
To determine whether preincubation with these scavenger agents 
could modulate apoptotic cell death after ALA-PDT, double staining 
with acridine orange/ ethidium bromide was performed. 10 min ALA-
PDT, a higher light dose than the previously determined LD50 (7 min), 
yielded 60.7 ± 1.7% late apoptotic cells while early apoptotic cells 
reached 37.7 ± 1.7%, totalizing 98.4 ± 3.4% apoptotic cells, indicating 
that the treatment was effective. Pre-incubation with scavenger agents 
considerably lowered apoptosis percentages down to 48.3 ± 2.7%, 58.8 
 
 
Figure  4.  Quantification of viable, apoptotic and necrotic cells after different ALA-PDT 
time dose.  
Once PDT was performed, 1 hr after cells were trypsinized and stained with acridine 
orange/ ethidium bromide, and visualized and counted by fluorescence microscopy (A), 
or labelled with Annexin V-FITC /propidium iodide and analyzed by flow cytometry (B). 
Bar colors: black ■: viable cells; dark grey ■: early apoptotic cells; light grey ■: apoptotic 
cells; white □: necrotic cells) (*: p < 0.05; *: p < 0.01; significance respect to untreated 
control cells).
Figure  5. Fluorescent images of cells incubated with ALA and MitoTracker Green or 
LysoTracker Green before and after PDT. 
Cells grown on coverslips were incubated 2.5 hr with 1 mM ALA ; then, 150 nM 
MitoTracker Green (upper panel) or LysoTracker Green (lower panel) were added and the 
incubation continued for 30 min (A, C). Plates were irradiated for 10 min and examined 
1 hr later by fluorescence microscopy for organelle morphology (B, D). Scale bar 10 µm.
Figure 6.  Porphyrin synthesis and cell survival after ALA-PDT in the presence of SA or 
Dfx. 
Cells were incubated with 1 mM Dfx or SA for 1 hr.  Then, 1 mM ALA was added and 
incubation continued for 3 hr. Cells were washed with PBS,  covered with 2 ml  5% HCl 
and incubated at 37°C for 20 min to extract  the intracellular porphyrins ( dark grey bars). 
Cell survival ( light grey bars) was determined at 1 hr after PDT by the MTT assay. (: 
p < 0.05; :p < 0.01, significance respect to values for incubation and irradiation in the 
presence of ALA).
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± 4.2, 64.3 ± 1.6%, 78.5 ± 3.1% and 74.6 ± 2.3% for Asc, Trx, Man, GSH 
and Trp, respectively (Figure 8 panel A, Figure 9A).
Similarly, preincubation with protective agents decreased the 
photodamage determined by Annexin V-FITC/ propidium iodide 
labelling. Again, Asc and Trx reduced significantly the signal for 
apoptotic cells from 26.8 ± 4.2% to 3.15 ± 0.35% and 1.2 ± 0.5% 
respectively. Man, GSH and Trp lowered apoptosis levels to 9.95 
± 4.45%, 18.3 ± 6.3% and 3.45 ± 0.25% respectively (Figure 8 panel 
B, Figure 9B). These results confirm those previously obtained with 
morphological apoptosis staining, although Trp showed a higher 
protection when analyzed by flow cytometry. 
These results imply that the extent of apoptosis was markedly 
reduced in scavengers pre-treated cells as compared to only ALA-
PDT treated cells. Moreover, cells pre-incubated with scavengers at 
the highest PG showed a FSC-SSC plot similar to those of control cells 
(Figure 3 panel F), indicating that cell morphology was apparently 
unaffected by ALA-PDT treatment when the protective agents are 
present during irradiation (Figure 8 panel C).
Scavengers modulate cell death after ALA-PDT via selective 
reduction of ROS
Production of several ROS after ALA-PDT can be detected by flow 
cytometry employing specific oxidizing fluorescent probes. Peroxides 
generation after ALA-PDT was determined by the use of H2-DCFDA, 
which is oxidized by peroxyl radicals, hydrogen peroxide and hydroxyl 
radicals. Singlet oxygen was detected thorough the selective oxidation 
of MVP. Superoxide anion production was monitored by the specific 
probe HE, and mitochondrial membrane potential (MMP) was 
analyzed by Rh123 which is taken up by polarized mitochondria.
Increased levels of reactive species were detected after ALA-PDT 
Figure 7. Effect of different concentrations of ROS scavenger agents on ALA-PDT. 
Cells were preincubated for 1 hr with ROS scavengers at non-toxic, non-photoactive 
concentrations ranging from 0.01 mM to 20 mM. ALA was added to a final concentration 
of 1 mM and incubation continued for 3 hr. Cells were irradiated for 10 min and 1 hr later 
the MTT assay was performed. Ratio between cell survival after ALA-PDT in the presence 
and in the absence of the scavenger agent was defined as Protection Grade (PG) for each 
scavenger (A: GSH; B: Trp; C: Man; D: Asc; E: Trx).
 
Figure 8. Cell morphology after 10 min ALA-PDT with 1 hr pre-incubation with different ROS scavenger agents. Cells were pre-incubated 1 hr with the scavengers at their highest PG concentration, then 
incubated with 1 mM ALA for 3 hr and irradiated for 10 min. After 1 hr, cells were trypsinized and stained with acridine orange and ethidium bromide (panel A) and visualized under fluorescence microscopy, 
or labelled with Annexin V-FITC / propidium iodide (panel B) and analyzed by flow cytometry.  Cell size and granularity were assessed by light scattering by flow cytometry as well (panel C).
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Figure 9. Quantification of viable, apoptotic and necrotic cells after 1 hr pre-incubation 
with different ROS scavenger and 10 min ALA-PDT.  
Cells were trypsinized 1 hr after photodynamic treatment and stained with acridine orange 
/ ethidium bromide and visualized under fluorescence microscopy (A), or labelled with 
Annexin V-FITC / propidium iodide and analyzed by flow cytometry (B).
Bar colors: black ■: Viable cells; dark grey ■: early apoptotic cells; light grey ■: apoptotic 
cells; white □: necrotic cells) (*: p < 0.05; *: p < 0.01, significance respect to 10 min ALA-
PDT values).
 
Figure 10.  Intracellular ROS detection and mitochondrial membrane potential after ALA-PDT. 
Positive cells were counted by flow cytometry for fluorescence of oxidized ROS specific probes (A). Bar colors: black ■: H
2
-DCFDA; dark grey ■: MVP; light grey ■: HE; white □: Rh 
123. Representative flow cytometry histograms for H
2
-DCFDA) (B), (MVP) (C), (HE) (D) and (Rh 123) (E) are shown. Cells were preincubated 1 hr with Asc and Trx at their highest PG 
concentration, incubated with 1 mM ALA for 3 hr and irradiated for 10 or 15 min. After 1 hr cells were trypsinized and loaded with H
2
-DCFDA (10 µM), MVP (10 µM), HE (2  µM) or Rh 
123 (10 µM) and incubated in the dark at 37°C for 30 min. Samples were analyzed by flow cytometry. (*: p < 0.05; *: p < 0.01, significance respect to 10 min ALA-PDT values).
 
(Figure 10A). Maximum levels for both peroxides and singlet oxygen, 
were found at 10 min ALA-PDT (H2-DCFDA positive cells: 69.3 ± 
5.6%; MVP positive cells: 83.5 ± 1.9%), which may be due to the ROS 
instability and short life. In addition, with lower time doses, such as 5 
min, levels were already high, according to the fast formation kinetics 
for ROS (data not shown). Superoxide anion reached its highest levels 
after 15 min irradiation (HE positive cells: 70.6,5 ± 8.1%) as well as cells 
with depolarized mitochondria (Rh 123 negative cells: 32.1 ± 11.1%).
Highly protective scavengers such as Asc and Trx were able to 
reduce peroxide radicals production (Asc and Trx pre-treated H2-
DCFDA positive cells: from 69.3 ± 5,6% to 50.7 ± 2.8% and 20.8 ± 0,5% 
respectively), but only Asc was effective at reducing singlet oxygen 
and superoxide anion levels (Asc and Trx pre-treated MVP positive 
cells: from 83.5 ± 1.9% to 25.4 ± 5.2% and 73.6 ± 3.4% respectively; 
Asc and Trx pre-treated HE positive cells: from 70.6,5 ± 8.1% to 2.8 ± 
1.3% and 34.6 ± 1.1% respectively). On the other hand, mitochondrial 
Teijo MJ (2016) Modulation of 5-Aminolevulinic acid mediated photodynamic therapy induced cell death in a human lung adenocarcinoma cell line
 Volume 3(3): 450-459Integr Cancer Sci Therap, 2016      doi: 10.15761/ICST.1000187
membrane depolarization was not significantly modified by scavenger 
pre-treatment. Incubation with scavengers before PDT resulted in 
light scatters similar to those of the control cells, indicating that cell 
morphology was slightly altered by the photodynamic treatment in the 
presence of scavengers (data not shown).
Discussion
With the exogenous administration of ALA, the negative feedback 
control that heme exerts over its own biosynthetic pathway is by-
passed, and the accumulation of PpIX is induced. In malignant cells 
PpIX accumulation is more pronounced compared to their normal 
counterparts, and this is the rationale underlying ALA-PDT [16,17]. 
The advantages of PDT over conventional cancer therapies rely on 
its neat and selective tumor cell killing. Generation of ROS, with the 
ability to cause severe damage to vital organelles in a restricted time 
window and therefore, limiting cell damage to surrounding normal 
tissue, induces a cell death process just as neat as its oxidative initiation: 
apoptosis.
In this work, we found that lung cancer A549 cells showed a 
light dose-dependent response to ALA-PDT, and apoptosis appears 
as the most extensive cell death process taking place shortly after the 
treatment. Apoptotic cell morphology increases even after a minor 
ALA-PDT dose of 5 min and become predominant after 10 min of 
light exposure; necrosis percentages remained low even at the highest 
dose tested. Although PDT can produce apoptosis or necrosis, or a 
combination of the two mechanisms, which appears to be dependent 
on the dose of PDT, ALA-PDT is highly efficient to induce apoptosis 
often at low doses, implying that lower doses than those needed to 
produce necrosis are very effective in producing the desired cell killing 
results which, however, do not exclude autophagy and lysosomal 
apoptosis participation in cell killing [28-31].
ALA-induced PpIX localized mainly at mitochondria as seen in 
confocal images. Regarding organelle damage, and in consistence with 
the PpIX localization, mitochondria appeared to be seriously affected by 
10 min ALA-PDT, which was expected not only for being the primary 
site of synthesis for PpIX, but also for being the site for the initiation of 
intrinsic apoptotic pathway. Localization of PS conditions the primary 
site for cell damage, since the photooxidative species formed after PDT 
have a short lifetime and diffusion distance [36,37]. As it was shown 
by loss of Rh 123 fluorescence in cells with depolarized mitochondria, 
MMP was increased after ALA-PDT, supporting the hypothesis for 
mitochondria as the site of cell death initiation. Lysosome disruption, 
although not a probable subcelular localization for PpIX, also emerged 
as a consequence of ALA-PDT. Most PS localizing at lysosomes can 
either delay or block the apoptotic program predisposing the cells to 
necrosis [26], which was not observed in our system. The lysosomal 
compartment is highly susceptible to oxidation and it was reported that 
permeabilization of lysosomal membranes does not precede MMP in 
cells photosensitized with hypericin [31]. 
Elucidating the behaviour of agents for PDT modulation is a useful 
tool to enhance cell death in malignant tissue and prevent it in normal 
cells [38]. It is expected that the iron chelator Dfx would enhance 
PDT-induced cell death by increasing heme precursors accumulation 
[39]. However, as an iron chelator, Dfx could also have reduced ROS 
generation by interfering with photochemical reactions. In our case, 
and in accordance to Fukuhara et al. report [39], Dfx was able to 
enhance cell death promoted by ALA-PDT; on the other hand, SA, by 
inhibiting the enzyme 5-aminolevulinic acid dehydratase, significantly 
reduced ALA- induced porphyrin synthesis almost to control levels 
and also decreased cell death after illumination.
Antioxidants, on the other hand, are primarily reducing agents 
prone to scavenge free radicals; consequently, antioxidants could 
compete with oxygen for quenching of the triplet sensitizer or can 
neutralize the generated reactive species, thus counteracting the effect 
of PDT [40-42]. 
There are several reports on the protective effect of certain 
antioxidants and reactive species scavengers against the lethal 
oxidative stress induced by photosensitization, however, their role is 
controversial as it was observed that in some cases they might increase, 
decrease or have no effect on PDT efficacy at all [41-45].
In general, antioxidants scavenging singlet oxygen (such as vitamin 
C) may decrease the effectiveness of PDT [24], while those increasing 
the amounts of singlet oxygen (such as mangostin) may exhibit a 
synergistic effect on PDT [46]. Many antioxidants can exhibit pro-
oxidant activity, especially in the presence of catalytic metals; the later 
the antioxidant is added to the system, the more it is prone to act as a 
pro-oxidant. [47]. The potential therapeutic gain of the application of 
certain radical scavenger during PDT lies for example, in preventing 
side effects of PDT such as skin sensibility [48].
Whether certain antioxidants demonstrate anti or pro-oxidant 
behaviour depends on the molecular structure, concentration and 
timing of addition, among others [41]. Characterization of these agents, 
frequently used to clinically minimize photodamage to normal tissue, 
is an important stage before assuming what their action will be; this is 
the reason why investigation on antioxidant effects on PDT becomes 
relevant.
The results we presented indicate that all compounds tested showed 
at least a slight protective effect on ALA-PDT. In particular, Trx and 
Asc exhibited the greatest protection against cell death induction 
as well as prevention of ROS generation. Among the antioxidants 
tested, Asc plays a central role in the defense of free radical-induced 
cellular damage exhibiting also anticancerinogenic, antimutagenic, 
antibacterial, antiviral and anti-inflammatory effects [49]. It is able to 
react and reduce all physiologically relevant ROS and reactive nitrogen 
species, including superoxide, hydroperoxyl radicals, aqueous peroxyl 
radicals, singlet oxygen, ozone, nitrogen dioxide, nitroxide radicals, 
and hypochlorous acid [24]. This may be the reason why it was so 
effective at reducing both peroxide and singlet oxygen flow cytometry 
signals. 
Trx is a water-soluble derivative of vitamin E and α-tocopherol 
analogue [50]; this main membrane-bound cellular antioxidant [51], 
in spite of having a broad spectrum of ROS scavenging, among which 
is hydrogen peroxide [52], was unable to significantly reduce the 
induction of singlet oxygen in our model. Besselnik et al. [53] reported 
protection of red blood cell suspension from photohemolysis against 
virus PDT inactivation by a combination of Tx and dipyridamole, 
however, Melnikova et al. [54] found an enhancement of meta-
tetrahydroxyphenylchlorin (mTHPC)-sensitized PDT performed on 
HT29 human colon adenocarcinoma xenografts in nude mice injected 
with Tx. 
GSH, Trp and Man increased viability by themselves or even in 
presence of light. Not only viability was increased by pre-incubation 
with scavengers, but also specific apoptotic features were prevented. 
Apoptosis assessed by flow cytometry detected higher percentages of 
viable cells in the presence of the scavengers compared to the controls 
incubated in the absence of the compounds. Protection by these agents 
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was revealed in consistence with morphological staining, For Trp, 
higher protection when analyzed by flow cytometry was observed 
compared to the morphological features; GSH, and Man presented 
heterogeneous and low PGs, although they were able to significantly 
reduce the percentages of apoptotic cells. 
These results indicate a grade of specificity for the scavenger 
agents, since their effects differ in the ROS species in which they have a 
significant action. Moreover, it is shown that ROS exert an important 
step in the early events following photodynamic treatment. 
Many cancer treatments combine conventional therapies with 
complementary and alternative medicine therapies. Within this 
context, the ability of some antioxidants to modulate the outcome 
of PDT, improving its efficacy in tumoral tissue and decreasing 
photodamage to normal tissue, is a promising achievement for the use 
of this non-invasive therapy.
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